Apriori Bio

Apriori Bio is ushering in a new era of AI-enabled vaccine design to improve global health outcomes. Our pioneering approach centers on a unique technology platform, Octavia™, that predicts viral evolution, delivers improved vaccines that elicit ideal immune responses, and assesses how well they will perform before entering clinical trials.